Precision Neurology

Pioneering diagnostics using neuron-derived exosomes

Scroll Down

We are a biotechnology company dedicated to the development of biomarkers and diagnostic solutions for neurological disorders.

contact us

NeuroDex Neurodiagnostic Platform

α-Syn

Biomarker

*Parkinson’s, MSA, Alzheimer’s diseases. Monitoring biological response to treatments, pharmacodynamic, pathway engagement biomarker, and treatment response.

TDP43

Biomarker

*ALS, FTD, Alzheimer's disease. Monitoring biological response to treatments, pharmacodynamic, pathway engagement biomarker, and treatment response.

Tau/pTau

Biomarker

*Alzheimer's disease. Monitoring biological response to treatments, pharmacodynamic, pathway engagement biomarker, and treatment response.

NF-L

Biomarker

*Brain injury and neuroinflammation. Monitoring biological response to treatments, pharmacodynamic, pathway engagement biomarker, and treatment response.

LC3

Biomarker

*Autophagy/lysosome across diseases. Monitoring biological response to treatments, pharmacodynamic, pathway engagement biomarker, and treatment response.

NF-kB

Biomarker

*Neuroinflammation across diseases. Monitoring biological response to treatments, pharmacodynamic, pathway engagement biomarker, and treatment response.

AKT panel

Biomarker

*Metabolic changes like GLP1. Monitoring biological response to treatments and pharmacodynamic.

Synaptic protein

Biomarker

*Synaptic plasticity across diseases. Monitoring biological response to treatments and pharmacodynamics.

01

Biomarker Discovery & Validation

Services

*Leverage brain-enriched exosomes to discover novel biomarkers for neurological diseases using immunoassays and RNA sequencing.

02

Translational Research Biomarkers

Services

*Partner with pharmaceutical and biotechnology companies to translate NDE biomarkers into clinically relevant endpoints for drug development.

01

Neuronal-Derived Exosome Isolation and Analysis

Services
02

Clinical Trial Biomarker Support

Services

*Biomarker services tailored for integration into Phase I–III clinical trials. Stratification, pharmacodynamic monitoring, and endpoint analysis.

Biomarker Discovery Solutions

NeuroDex provides advanced biomarker discovery solutions that integrate seamlessly into clinical workflows. Our neuron-derived extracellular vesicle (NDE) panels enable precise disease detection, monitoring, and treatment evaluation. Validated under GLP and CLIA standards, our solutions support personalized diagnostics, enhance patient care, and optimize therapeutic strategies.

Regulatory Compliance

Clinical Trial Support

Enhanced Diagnostic Accuracy

Personalized Monitoring

01

Parkinson's disease and synucleopathy

*a-syn biomarker, novel biomarker discovery

view more
02

ALS

*TDP43 biomarker, novel biomarker discovery

view more
03

Alzheimer's disease

*Tau/pTau, A-syn, biomarkers, novel biomarker discovery

view more
04

Neuroinflamation

*NF-kB biomarker, novel biomarker discovery

view more
05

Autophagy, Brain injury

*LC3 biomarker, novel biomarker discovery

view more
w
w
w